TY - JOUR
T1 - Surgical treatment of gastrinomas: a single-centre experience
AU - Atema, Jasper J.
AU - Amri, Ramzi
AU - Busch, Olivier R. C.
AU - Rauws, Erik A. J.
AU - Gouma, Dirk J.
AU - Nieveen van Dijkum, Els J. M.
PY - 2012
Y1 - 2012
N2 - Background Gastrinomas are rare neuroendocrine tumours, and responsible for ZollingerEllison syndrome (ZES). Surgery is the only treatment that can cure gastrinomas. The success of surgical treatment of gastrinomas in a single centre was evaluated. Methods A retrospective review of all patients who underwent resection for a gastrinoma between 1992 and 2011 at a single institution was performed. Presentation, diagnostics, operative management and outcome were analysed. Results Eleven patients with a median age of 46?years were included. All patients had fasting hypergastrinaemia and a primary tumour was localized using imaging studies in all patients. A pylorus-preserving pancreaticoduodenectomy was performed in three patients: two patients underwent duodenectomy and one patient central pancreatectomy. The remaining five patients underwent enucleation. A primary tumour was removed in nine patients: five tumours were situated in the pancreas, three in the duodenum and one patient was considered to have a primary lymph node gastrinoma. The median follow-up was 3?years (range 115) after which 7 patients were disease-free and 3 patients had (suspected) metastatic disease. One patient died 13 years after initial surgery. Conclusion The success of surgical treatment of a gastrinoma in this series was 7/11 with a median follow-up of 3?years; comparable to recent published studies
AB - Background Gastrinomas are rare neuroendocrine tumours, and responsible for ZollingerEllison syndrome (ZES). Surgery is the only treatment that can cure gastrinomas. The success of surgical treatment of gastrinomas in a single centre was evaluated. Methods A retrospective review of all patients who underwent resection for a gastrinoma between 1992 and 2011 at a single institution was performed. Presentation, diagnostics, operative management and outcome were analysed. Results Eleven patients with a median age of 46?years were included. All patients had fasting hypergastrinaemia and a primary tumour was localized using imaging studies in all patients. A pylorus-preserving pancreaticoduodenectomy was performed in three patients: two patients underwent duodenectomy and one patient central pancreatectomy. The remaining five patients underwent enucleation. A primary tumour was removed in nine patients: five tumours were situated in the pancreas, three in the duodenum and one patient was considered to have a primary lymph node gastrinoma. The median follow-up was 3?years (range 115) after which 7 patients were disease-free and 3 patients had (suspected) metastatic disease. One patient died 13 years after initial surgery. Conclusion The success of surgical treatment of a gastrinoma in this series was 7/11 with a median follow-up of 3?years; comparable to recent published studies
U2 - https://doi.org/10.1111/j.1477-2574.2012.00551.x
DO - https://doi.org/10.1111/j.1477-2574.2012.00551.x
M3 - Article
C2 - 23134185
SN - 1365-182X
VL - 14
SP - 833
EP - 838
JO - HPB: The official journal of the International Hepato Pancreato Biliary Association
JF - HPB: The official journal of the International Hepato Pancreato Biliary Association
IS - 12
ER -